Skip to main content

Hormones

What each one actually does.

Estrogen, progesterone, testosterone, FSH. What they supported, what happens when they fall or fluctuate, and what replacing does and doesn't do. No scare, no sell.

Three hormone cards and the pathway diagram are free. Saved picks stay on this device.

Three hormones, three different jobs

Free to read and save here. No account needed. Grades apply to the named evidence, not your personal treatment eligibility.

Estrogen

Grade B

Estrogen supports bone and genital tissues and acts in brain networks involved in temperature, memory and attention. Research suggests links with dopamine signalling, but that doesn’t mean estrogen replacement reliably fixes brain fog.

What replacing can and can't do

Systemic MHT treats hot flashes and prevents bone loss. It isn’t recommended to prevent dementia. Local vaginal estrogen targets dryness, irritation and some urinary symptoms.

Grade B is a cautious overview label; dopamine mechanisms are less certain than bone and hot-flash treatment evidence.

Source · 2015Read estrogen

Progesterone

Grade B

Progesterone changes after ovulation. Its metabolites act on brain signalling involved in sleep and mood. Responses differ: some people feel calmer; others are sensitive to changes.

What replacing can and can't do

Micronized progesterone may improve some sleep outcomes. When systemic estrogen is used with a uterus, a progestogen usually protects the uterine lining. It isn’t a guaranteed mood or sleep treatment.

Grade B for sleep outcomes; small trials and different formulations limit certainty.

Source · 2021Read progesterone

Testosterone

Grade B

Testosterone contributes to sexual function and muscle biology. It tends to change with age rather than follow a single menopause drop. Both-ovary removal can change that picture.

What replacing can and can't do

The supported treatment indication is persistent, distressing low desire after menopause, following assessment. Trials don’t establish testosterone as a treatment for muscle gain, brain fog, mood, bone density or general energy.

Grade B for the focused low-desire discussion, not a muscle-building or energy claim.

Source · 2019Read testosterone

Hormone pathways

Perimenopause often brings fluctuating estrogen and less predictable ovulation. Lower estrogen becomes more sustained after menopause. Symptoms have other causes too.

Estrogen fluctuates, then falls

Temperature regulation, brain networks, bone and genital tissues

Hot flashes, brain fog, interrupted sleep, dryness and bone loss

Ovulation becomes less predictable

Progesterone patterns change; sleep and mood signalling can be affected

Sleep and mood changes vary. Other causes still deserve attention

FSH often rises

The brain sends a stronger signal as ovarian feedback changes

FSH is a signal, not a symptom. A single test often can’t explain perimenopause

A simplified pathway, not a test of what caused your symptoms. Genital and urinary changes are sometimes called GSM. Sources: NICE NG23 and Brinton et al., 2015.

What this page is based on

The menopause transition involves brain and hormone signalling; mechanisms don't establish that MHT treats every cognitive symptom.

Mechanism / basic scienceBrinton et al., Nature Reviews Endocrinology · 2015

Mechanistic review. The card's broad Grade B label doesn't upgrade the certainty of every proposed dopamine pathway.

Read the source

Micronized progesterone may improve some sleep outcomes, but study designs and co-treatments vary.

Systematic reviewNolan et al., Journal of Clinical Endocrinology & Metabolism · 2021

Sleep findings don't establish a universal mood benefit.

Read the source

Testosterone has a focused evidence-based indication for distressing low desire after menopause, not general muscle or cognitive enhancement.

Clinical guidelineGlobal Consensus Position Statement on Testosterone Therapy for Women · 2019
Read the source

MHT treats vasomotor symptoms and prevents bone loss; it's not recommended to prevent dementia.

Clinical guidelineThe Menopause Society hormone therapy position statement · 2022
Read the source

Diagnosis, early menopause assessment and treatment decisions depend on context rather than one hormone reading.

Clinical guidelineNICE NG23 · 2024
Read the source
How we grade A–D

Where next?